The region’s biggest venture capital raise of the year belongs to RegenxBio.
The Rockville-based biotech company has closed a $70.5 million Series D round led by new investor Vivo Capital, a Silicon Valley health care backer, and existing investors Venrock and Brookside Capital.
{iframe}http://www.bizjournals.com/baltimore/blog/cyberbizblog/2015/05/maryland-biotech-firm-lands-regions-biggest.html{/iframe}